Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral and host lipid membranes are fundamental structural components consisting of phospholipid bilayers that serve as the primary barrier and interface for cellular and viral processes (Wikipedia). In the context of virology, the viral envelope is a lipid bilayer derived from the host cell's own membranes during the budding process, embedded with viral glycoproteins (NIH). These membranes are critical for the viral life cycle, facilitating attachment, fusion, and entry into the host cell, as well as the eventual egress of progeny virions (PubMed, PMID: 20386714). Therapeutic targeting of these membranes often focuses on inhibiting the fusion of the viral envelope with the host cell membrane or disrupting the lipid organization of the envelope itself (StatPearls). Because the viral envelope is host-derived, it presents a unique target for broad-spectrum antivirals, though selectivity remains a challenge to avoid host cell toxicity (Journal of Virology). Drugs like docosanol and various membrane-disrupting peptides exploit the physical properties of these bilayers to prevent infection (PubChem).
Drugs targeting these membranes typically act by inhibiting the fusion of the viral envelope with the host cell plasma membrane, disrupting the lipid bilayer integrity, or altering membrane fluidity to prevent viral entry and exit (PubMed, PMID: 20386714; PubChem).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral and host lipid membranes.